Dipsanoside B exhibits significant anti-inflammatory and immunomodulatory properties, making it a compound of interest in the development of therapeutics for chronic inflammatory diseases. It has been studied for its ability to inhibit key pro-inflammatory cytokines such as TNF-α and IL-6, which play central roles in conditions like rheumatoid arthritis and inflammatory bowel disease. Additionally, Dipsanoside B demonstrates neuroprotective effects in preclinical models, suggesting potential use in treating neurodegenerative disorders such as Alzheimer’s disease. Its natural origin and low cytotoxicity profile further support its evaluation as a lead compound in drug discovery, particularly for diseases where oxidative stress and inflammation are intertwined.